Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies

Muhammad A. Alvi(Queen's University Belfast), Manuel Salto‐Tellez(Queen's University Belfast), Richard Turkington(Queen's University Belfast), Stephen McQuaid(Queen's University Belfast), Richard H. Wilson(Arizona State University), Jacqueline A. James(Queen's University Belfast), Wendy Moore(Queen's University Belfast), Victoria Bingham, Philip D. Dunne(Queen's University Belfast), Claire McGready(Queen's University Belfast), Maurice B. Loughrey(Queen's University Belfast), Graeme I. Murray(University of Aberdeen), Marc-Aurel Fuchs(Queen's University Belfast), Mark Lawler(Queen's University Belfast), Brendan Pang(National University Hospital), Perry Maxwell(Queen's University Belfast)
British Journal of Cancer
June 8, 2017
Cited by 57


Related Papers